anti-PD-1/VEGF-A DARPins (Molecular Partners)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Nameanti-PD-1/VEGF-A DARPins (Molecular Partners)
Drug Alias NamePD-1 checkpoint inhibitor (Molecular Partners)
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionProgrammed cell death protein 1 blockersSerum albumin modulatorsVascular endothelial growth factor A inhibitors
TargetsSerum albuminVascular endothelial growth factor AProgrammed cell death protein 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMolecular Partners Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMolecular Partners Ag
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A